These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 38244014)
1. Efficacy of EDS-FLU for Chronic Rhinosinusitis: Two Randomized Controlled Trials (ReOpen1 and ReOpen2). Palmer JN; Adappa ND; Chandra RK; Davis GE; Mahdavinia M; Messina J; Ow RA; Patel ZM; Peters AT; Sacks H; Schlosser RJ; Sindwani R; Soler ZM; White AA; Wise SK; Mahmoud RA J Allergy Clin Immunol Pract; 2024 Apr; 12(4):1049-1061. PubMed ID: 38244014 [TBL] [Abstract][Full Text] [Related]
2. NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps. Sindwani R; Han JK; Soteres DF; Messina JC; Carothers JL; Mahmoud RA; Djupesland PG Am J Rhinol Allergy; 2019 Jan; 33(1):69-82. PubMed ID: 30477309 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of the exhalation delivery system with fluticasone in patients with chronic rhinosinusitis with nasal polyps whose symptoms recur after sinus surgery. Ow RA; Soler ZM; Sindwani R; Leopold DA; Lee JT; Mahmoud RA; Han JK Int Forum Allergy Rhinol; 2023 Jan; 13(1):31-41. PubMed ID: 35674488 [TBL] [Abstract][Full Text] [Related]
4. EDS-FLU efficacy in patients with chronic rhinosinusitis with or without prior sinus surgery in ReOpen1 and ReOpen2 randomized controlled trials. Wise SK; Adappa ND; Chandra RK; Davis GE; Mahdavinia M; Mahmoud R; Messina J; Palmer JN; Patel ZM; Peters AT; Schlosser RJ; Sindwani R; Soler ZM; White AA Int Forum Allergy Rhinol; 2024 Dec; 14(12):1892-1903. PubMed ID: 39186196 [TBL] [Abstract][Full Text] [Related]
5. NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis. Leopold DA; Elkayam D; Messina JC; Kosik-Gonzalez C; Djupesland PG; Mahmoud RA J Allergy Clin Immunol; 2019 Jan; 143(1):126-134.e5. PubMed ID: 29928924 [TBL] [Abstract][Full Text] [Related]
6. What is the evidence for fluticasone exhalation delivery system in chronic rhinosinusitis? Kovacs AJ; Goshtasbi K; Kuan EC Curr Opin Otolaryngol Head Neck Surg; 2020 Feb; 28(1):14-17. PubMed ID: 31789927 [TBL] [Abstract][Full Text] [Related]
7. Exhalation Delivery Systems for Application of Intranasal Corticosteroids. Kovacs AJ; Adappa ND; Kuan EC Ear Nose Throat J; 2021 Jun; 100(5):309-313. PubMed ID: 33305974 [TBL] [Abstract][Full Text] [Related]
8. EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps. Sher MR; Steven GC; Romett JL; Pien G; LeBenger K; Messina JC; Carothers JL; Mahmoud RA; Djupesland PG Rhinology; 2020 Feb; 58(1):25-35. PubMed ID: 31815255 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of the exhalation delivery system with fluticasone in patients who remain symptomatic on standard nasal steroid sprays. Senior BA; Schlosser RJ; Bosso J; Soler ZM Int Forum Allergy Rhinol; 2021 May; 11(5):837-845. PubMed ID: 32970395 [TBL] [Abstract][Full Text] [Related]
10. Effects of Fluticasone Exhalation Delivery System in Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review. Wu D; Huang T; Wei Y Am J Rhinol Allergy; 2022 Mar; 36(2):176-184. PubMed ID: 34342516 [TBL] [Abstract][Full Text] [Related]
11. Different types of intranasal steroids for chronic rhinosinusitis. Chong LY; Head K; Hopkins C; Philpott C; Burton MJ; Schilder AG Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011993. PubMed ID: 27115215 [TBL] [Abstract][Full Text] [Related]
12. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Chong LY; Head K; Hopkins C; Philpott C; Schilder AG; Burton MJ Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011996. PubMed ID: 27115217 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of fluticasone exhalation delivery system in the management of chronic rhinosinusitis: what is the evidence? Kuan EC; Kovacs AJ; Workman AD; Bosso JV; Adappa ND Int Forum Allergy Rhinol; 2019 May; 9(S1):S16-S21. PubMed ID: 31087635 [TBL] [Abstract][Full Text] [Related]
16. EXHANCE-12: 1-year study of the exhalation delivery system with fluticasone (EDS-FLU) in chronic rhinosinusitis. Palmer JN; Jacobson KW; Messina JC; Kosik-Gonzalez C; Djupesland PG; Mahmoud RA Int Forum Allergy Rhinol; 2018 Jun; 8(8):869-76. PubMed ID: 29856520 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428 [TBL] [Abstract][Full Text] [Related]